Personalis, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Quarterly earnings show how the company performed and help investors track progress over time.
Earnings announcements let investors know how much money the company made or lost recently.
A major merger combines two companies; investors need to understand the deal's terms and impact.
Merger information helps investors understand risks and potential benefits of the combined company.
Expanded Medicare coverage increases potential customers for the company's medical tests.
Stockholder votes on directors and auditors show who oversees the company's finances and decisions.
Wider insurance coverage means more doctors and patients can use Personalis tests, boosting sales.
Stocky reads Personalis, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Personalis, Inc.'s most recent tracked filing was a 10-Q on 4 Aug 2026: Second quarter 2026 financial results reported.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.